Presentation

Publikationer

2023

2022

Johnny Ludvigsson, Linnea Eriksson, Christoph Nowak, Pedro F. Teixeira, Martina Widman, Anton Lindqvist, Rosaura Casas, Marcus Lind, Ulf Hannelius (2022) Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol BMJ Open, Vol. 12, Artikel e061776 Vidare till DOI
Christoph Nowak, Marcus Lind, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A. Martinez-Brocca, Mari Sol Ruiz de Adana, Jeanette Wahlberg, Ragnar Hanas, Cristina Hernandez, Maria Clemente-Leon, Ana Gomez-Gila, Marta Ferrer Lozano, Theo Sas, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Ulf Hannelius, Rosaura Casas, Johnny Ludvigsson (2022) Intralymphatic GAD-Alum (Diamyd (R)) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2 Journal of Clinical Endocrinology and Metabolism, Vol. 107, s. 2644-2651 Vidare till DOI

Forskning

Nyheter

Organisation